The interest in graphene-based nanomaterials (GBNs) application in nanomedicine, in
particular in neurology, steadily increased in the last decades. GBNs peculiar physical …

Despite the impressive strides in the research community, numerous obstacles pose marked
challenges in the treatment of central nervous system (CNS) disorders. The limitations of …

In neuroinflammation, astrocytes play multifaceted roles that regulate the neuronal
environment. Astrocytes sense and respond to pro-inflammatory cytokines (CKs) and, by a …

Seizures represent a frequent symptom in gliomas and significantly impact patient morbidity
and quality of life. Although the pathogenesis of tumor-related seizures is not fully …

Nanoscale graphene-based materials (GBMs) enable targeting subcellular structures of the
nervous system, a feature crucial for the successful engineering of alternative nanocarriers …

Engineered small graphene oxide (s-GO) sheets were previously shown to reversibly down-
regulate glutamatergic synapses in the hippocampus of juvenile rats, disclosing an …

Small graphene oxide (s‐GO) nanosheets reversibly downregulate central nervous system
(CNS) excitatory synapses, with potential developments as future therapeutic tools to treat …

Rapid progress in nanotechnology has advanced fundamental neuroscience and innovative
treatment using combined diagnostic and therapeutic applications. The atomic scale …

Graphene oxide (GO), a promising biomedical nanomaterial, has attracted increasing
attention regarding its potential hazards to environment and health. However, data on its …

Synaptic plasticity is an important basis of learning and memory and participates in brain
network remodelling after different types of brain injury (such as that caused by …